Jeevan Therapeutics
Jeevan Therapeutics
  • Home
  • Our Approach
  • Our Progress
  • About
  • Contact Us
  • More
    • Home
    • Our Approach
    • Our Progress
    • About
    • Contact Us
  • Sign In
  • My Account

  • Signed in as:

  • filler@godaddy.com

  • My Account

  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Our Approach
  • Our Progress
  • About
  • Contact Us

Account

  • My Account

  • Sign out

  • Sign In
  • My Account

A NEW APPROACH TO DURABLE REMISSION

A NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSION

Advancing next-generation bispecific nanobody therapeutics for autoimmune diseases, beginning with Crohn's disease. 

A NEW APPROACH TO DURABLE REMISSION

A NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSIONA NEW APPROACH TO DURABLE REMISSION

Advancing next-generation bispecific nanobody therapeutics for autoimmune diseases, beginning with Crohn's disease. 

Beyond Conventional Therapy

Autoimmune diseases involve complex biological processes that are not always adequately addressed by existing therapies. Jeevan's bispecific nanobody platform is designed to bring complementary therapeutic strategies together in a single molecule, with the potential to deliver more comprehensive disease control.

Innovation in Crohn's Disease

 

Jeevan is advancing a differentiated therapeutic approach designed to address the challenges of disease persistence and relapse.

Read Our October 2026 Update

About Us

Our Mission

 

Jeevan Therapeutics is developing next-generation bispecific nanobody therapeutics for autoimmune disease, beginning with Crohn’s disease. Our lead program is designed to address two complementary, validated biological pathways involved in disease persistence and relapse, with the goal of achieving deeper and more durable disease control.


Crohn’s is our lead indication and where we’ve built the development strategy. We see broader autoimmune potential for the approach, but we’re being disciplined about establishing the biology and product profile in Crohn’s before moving into additional indications.


Contact Us

contact@jeevantx.com

Copyright © 2026 Jeevantx - All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept